Loading...
Projects / Programmes
A double whammy for the NF-κB signalling pathway: development of TAK1 and IKKβ degraders against inflammation-driven diseases
Research activity
| Code | Science | Field | Subfield |
|---|---|---|---|
| 1.09.00 | Natural sciences and mathematics | Pharmacy |
| Code | Science | Field |
|---|---|---|
| 3.01 | Medical and Health Sciences | Basic medicine |
Evaluation
(metodology)
Points
4,575.26
A''
1,092.72
A'
2,699.32
A1/2
3,537.08
CI10
7,334
CImax
189
h10
44
A1
17.1
A3
0.09
Data for the last 5 years (citations for the last 10 years) on
September 22, 2026;
Data for score A3 calculation refer to period
2021-2025
Data for ARIS tenders (
04.04.2019 – Programme tender,
archive
)
Citations
Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
| Database | Linked records | Citations | Pure citations | Average pure citations |
|---|---|---|---|---|
| WoS | 347 | 8,134 | 6,859 | 19.77 |
| Scopus | 353 | 8,904 | 7,524 | 21.31 |
Organisations (1) , Researchers (7)
0787 University of Ljubljana, Faculty of Pharmacy
| no. | Code | Name and surname | Research area | Role | Period | No. of publicationsNo. of publications |
|---|---|---|---|---|---|---|
| 1. | 53656 | Pharmacy | Researcher | 2024 - 2026 | 42 | |
| 2. | 32034 | Oncology | Researcher | 2024 - 2026 | 242 | |
| 3. | 36438 | Pharmacy | Researcher | 2024 - 2026 | 291 | |
| 4. | 62029 | Pharmacy | Researcher | 2026 | 0 | |
| 5. | 30816 | Pharmacy | Head | 2024 - 2026 | 305 | |
| 6. | 52378 | Pharmacy | Researcher | 2024 - 2026 | 48 | |
| 7. | 28334 | Pharmacy | Researcher | 2024 - 2026 | 477 |